60 Degrees Pharmaceuticals (SXTP) Insider Trading & Ownership $0.45 -0.02 (-4.74%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.45 +0.00 (+0.89%) As of 02/21/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends 60 Degrees Pharmaceuticals (NASDAQ:SXTP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.27%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$90,909.60Number OfInsiders Selling(Last 12 Months)0 Get SXTP Insider Trade Alerts Want to know when executives and insiders are buying or selling 60 Degrees Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SXTP Insider Buying and Selling by Quarter 60 Degrees Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/16/2024Cheryl XuDirectorBuy2,000$1.45$2,900.00 12/12/2024Cheryl XuDirectorBuy5,000$1.82$9,100.00 12/9/2024Geoffrey S DowCEOBuy35,823$1.27$45,495.21 12/5/2024Geoffrey S DowCEOBuy17,549$1.11$19,479.39 11/21/2024Geoffrey S DowCEOBuy3,500$0.91$3,185.00 11/19/2024Geoffrey S DowCEOBuy2,500$0.90$2,250.00 8/27/2024Cheryl XuDirectorBuy5,000$1.70$8,500.00 (Data available from 1/1/2013 forward) SXTP Insider Trading Activity - Frequently Asked Questions Who is on 60 Degrees Pharmaceuticals's Insider Roster? The list of insiders at 60 Degrees Pharmaceuticals includes Cheryl Xu, and Geoffrey S Dow. Learn more on insiders at SXTP. What percentage of 60 Degrees Pharmaceuticals stock is owned by insiders? 10.27% of 60 Degrees Pharmaceuticals stock is owned by insiders. Learn more on SXTP's insider holdings. Which 60 Degrees Pharmaceuticals insiders have been buying company stock? The following insiders have purchased SXTP shares in the last 24 months: Cheryl Xu ($20,500.00), and Geoffrey S Dow ($70,409.60). How much insider buying is happening at 60 Degrees Pharmaceuticals? Insiders have purchased a total of 71,372 SXTP shares in the last 24 months for a total of $90,909.60 bought. 60 Degrees Pharmaceuticals Key ExecutivesDr. Geoffrey Stuart Dow (Age 50)Chairman, CEO & President Compensation: $125.56kMr. Tyrone Miller (Age 49)CFO & Treasurer Compensation: $135.63kDr. Bryan Smith (Age 58)Chief Medical Officer Ms. Kristen Landon (Age 57)Chief Commercial Officer Ms. Jennifer HerzDirector More Insider Trading Tools from MarketBeat Related Companies Scilex Insider Ownership Protara Therapeutics Insider Ownership IGM Biosciences Insider Ownership Aligos Therapeutics Insider Ownership Vistagen Therapeutics Insider Ownership Clearside Biomedical Insider Ownership Assertio Insider Ownership Pyxis Oncology Insider Ownership Karyopharm Therapeutics Insider Ownership ZIVO Bioscience Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:SXTP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredAmerica cannot power AIThere’s a fatal flaw at the heart of the AI revolution… With AI continuing to explode in popularity, tech c...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredHas Trump finally met his match?A new Chinese AI software called "DeepSeek" is sending shockwaves through the market. It's advanced enough ...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 60 Degrees Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 60 Degrees Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.